Chinese Journal of Clinical Hepatology 2013 Issue 1 Relation of TNF-alpha and IL-6 in serum and bile of patients with acute obstructive suppurative cholangitis

Relation of TNF-alpha and IL-6 in serum and bile of patients with acute obstructive suppurative cholangitis
WEI Guoqiang;FU Hanzhong;WANG Zhongyu;et al.

..............page:75-76,81

Role of glypican-3 signaling pathways and therapeutic potential in hepatocellular carcinoma
CHEN Jie;YAO Min;YAO Dengfu.

..............page:77-81

zhu bian zhi ci
jia ji dong niu jun qi

..............page:1

Recommendation on antiviral therapy to hepatitis B/C virus related hepatocellular carcinoma
Liver Cancer Study Group;Chinese Society of Hepatology;Chinese Medical Association

..............page:5-9

Drug resistance to nucleoside and nucleotide analogs in chronic hepatitis B and its management
Experts Attending the Disscussion on Hepatitis B Virus Drug Resistance

..............page:10-17

wei sheng su a que fa yu hcv man xing gan ran he gan rao su de kang bing du zhi liao wu ying da xiang guan
chi xiu mei

..............page:27

fei zuo ti lei kang yan yao wu de ying yong , man xing gan zang ji bing , gan xi bao ai
zhang ming zuo niu jun qi

..............page:53

Loco-regional therapy for liver cancer
YE Shenglong.

..............page:28-31

Recent perspectives in hepatocellular carcinoma(HCC) diagnosis and treatment
WANG Aiping;WEN Chunyang.

..............page:32-35

Comprehensive intervention treatment for hepatocellular carcinoma
BAI Wei;HAN Guohong.

..............page:36-37,41

Clinical value of susceptibility-weighted imaging for studying the multi-step hepatocarcinogenic process of cirrhotic liver nodules
ZENG Mengsu;LI Ruokun.

..............page:38-41

Clinicopathological study of intrahepatic bile duct cancers from 1982 to 2011
ZHU Zhen;CONG Wenming.

..............page:42-44

Pathological and differential diagnoses of exocrine pancreatic tumors
CHEN Jie.

..............page:45-49

Diagnostic and therapeutic value of endoscopic ultrasonography for pancreatic cancer
ZHANG Wenying;JIN Zhendong.

..............page:50-53

Solid pseudopapillary tumors of the pancreas:27 cases from a single institution
ZHOU Haiyang;WU Jianhui;HAO Chunyi.

..............page:54-57

Instructions for Authors

..............page:82-87

Differential expression of OPN,VEGF-A,and HIF-1α and its clinical significance in hepatocellular carcinoma
ZHENG Yan;ZHANG Chunqing;WANG Qizhi;et al.

..............page:58-61

Differential expression of liver-intestine cadherin in hepatocellular carcinoma and its clinical significance
QIU Shi;DONG Weiguo;YANG Zirong;et al.

..............page:62-64

Expression of transcription factor Sp1 in hepatocellular carcinoma
FENG Jie;TANG Zhenghao;YU Yongsheng.

..............page:65-67

Effect of sorafenib and celecoxib combination therapy on proliferation of the human cholangiocarcinoma cell line SK-ChA-1 in vitro
WAN Yunyan;LI Ling;HUANG Junli;et al.

..............page:68-71

Application of cryoprecipitate in patients treated by portaazygous devascularization
YANG Zhaoxu;YU Hengchao;WANG Desheng;et al.

..............page:72-74

bing xing gan yan bing du you dao yi dao xi bao si wang de xin ji zhi
li yin ping niu jun qi

..............page:24

Norms and clinical interpretation guidelines from the Hepatology Branch of the Chinese Medical Association
CHEN Xiaoping;ZHANG Zhiwei.

..............page:25-27

Explanation of the “Recommendation on antiviral therapy to hepatitis B/C virus related hepatocellular carcinoma”
DONG Jing;JIANG Jiaji.

..............page:20-24

Key points of AASLD practice guideline for management of hepatocellular carcinoma
LIN Su;JIANG Jiaji.

..............page:18-19

lin chuang gan dan bing za zhi 2013 nian 1 9 qi zhong dian hao xuan ti yu gao

..............page:4

Current perspectives in preventive and therapeutic strategies for hepatocellular carcinoma
YANG Yongping.

..............page:1-4